Skip to main content

Adaptimmune Therapeutics PLC

ADAPY
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001621227

No open-market purchases or sales by Adaptimmune Therapeutics PLC insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

13F holders, Q4 2022

Institutional positions in Adaptimmune Therapeutics PLC as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
69
+2 vs. Q3 2022
Shares held
114.0M
+174.5K (+0.2%) vs. Q3 2022
Total value
$166.3M
+$44.0M (+36.0%) vs. Q3 2022
New holders
15
16 more added
Sold out
13
23 more reduced

1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ADAPY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2022: 69 institutions
Q1 2021: 84 institutionsQ2 2021: 82 institutionsQ3 2021: 92 institutionsQ4 2021: 85 institutionsQ1 2022: 80 institutionsQ2 2022: 77 institutionsQ3 2022: 68 institutionsQ4 2022: 69 institutionsQ1 2023: 65 institutionsQ2 2023: 89 institutionsQ3 2023: 79 institutionsQ4 2023: 79 institutionsQ1 2024: 80 institutionsQ2 2024: 76 institutionsQ3 2024: 81 institutionsQ4 2024: 80 institutionsQ1 2025: 67 institutionsQ2 2025: 65 institutionsQ3 2025: 55 institutionsQ4 2025: 10 institutionsQ1 2026: 1 institutionQ2 2026: 0 institutions
Value heldQ4 2022: $166.3M
Q1 2021: $623.8MQ2 2021: $475.7MQ3 2021: $577.3MQ4 2021: $425.9MQ1 2022: $229.2MQ2 2022: $195.1MQ3 2022: $122.4MQ4 2022: $166.3MQ1 2023: $126.4MQ2 2023: $133.9MQ3 2023: $115.7MQ4 2023: $113.9MQ1 2024: $256.1MQ2 2024: $150.0MQ3 2024: $144.1MQ4 2024: $67.0MQ1 2025: $22.9MQ2 2025: $27.7MQ3 2025: $5.47MQ4 2025: $79.7KQ1 2026: $72Q2 2026: $0
Institutions holding ADAPY and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20261$72
Q4 202510$79.7K
Q3 202555$5.47M
Q2 202565$27.7M
Q1 202567$22.9M
Q4 202480$67.0M
Q3 202481$144.1M
Q2 202476$150.0M
Q1 202480$256.1M
Q4 202379$113.9M
Q3 202379$115.7M
Q2 202389$133.9M
Q1 202365$126.4M
Q4 202269$166.3M
Q3 202268$122.4M
Q2 202277$195.1M
Q1 202280$229.2M
Q4 202185$425.9M
Q3 202192$577.3M
Q2 202182$475.7M
Q1 202184$623.8M

Institutions, Q4 2022

Shares, value and share of portfolio for each institution holding Adaptimmune Therapeutics PLC; share changes are against Q3 2022.

Institutions holding ADAPY in Q4 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Matrix Capital Management Company, LP38,974,185$56.9M1.09%00.0%Unchanged
Baillie Gifford & Co17,169,939$25.1M0.03%+2,505,003+17.1%Added
NEA Management Company, LLC17,079,779$24.9M1.40%−2,8330.0%Reduced
Baker Bros. Advisors LP9,830,877$14.4M0.09%00.0%Unchanged
Long Focus Capital Management, LLC5,283,639$7.71M1.27%+494,149+10.3%Added
PFM Health Sciences, LP4,843,510$7.07M0.30%−4,477,074−48.0%Reduced
Bank of America Corp4,738,612$6.92M0.00%+3,703,418+357.8%Added
Rock Springs Capital Management LP2,676,536$3.91M0.09%+318,992+13.5%Added
Morgan Stanley2,289,848$3.34M0.00%+22,082+1.0%Added
Endurant Capital Management LP1,733,236$2.53M1.03%−55,281−3.1%Reduced
FMR LLC1,578,783$2.31M0.00%00.0%Unchanged
Syncona Portfolio Ltd1,377,294$2.01M3.19%00.0%Unchanged
JPMorgan Chase & Co1,001,112$1.46M0.00%−5,720−0.6%Reduced
BlackRock Inc.972,989$1.42M0.00%−441,258−31.2%Reduced
Renaissance Technologies LLC560,973$819.0K0.00%−5,259−0.9%Reduced
Acadian Asset Management LLC525,494$760.0K0.00%+413,926+371.0%Added
Rathbone Brothers plc432,818$631.9K0.01%00.0%Unchanged
DAFNA Capital Management LLC351,064$512.6K0.14%00.0%Unchanged
Key Client Fiduciary Advisors, LLC296,740$433.2K0.30%−139,245−31.9%Reduced
State Street Corp268,798$392.4K0.00%−40,500−13.1%Reduced
Kettle Hill Capital Management, LLC261,411$381.7K0.08%+8,277+3.3%Added
Citadel Advisors LLC242,637$354.3K0.00%−1,295,049−84.2%Reduced
Millennium Management LLC164,659$240.0K0.00%+153,255+1,343.9%Added
Gsa Capital Partners LLP141,084$206.0K0.03%−239,959−63.0%Reduced
Goldman Sachs Group Inc140,899$205.7K0.00%−304,294−68.4%Reduced
Geode Capital Management, LLC105,910$154.0K0.00%+33,141+45.5%Added
Lazard Asset Management LLC98,590$143.0K0.00%+98,590New
Marshall Wace, LLP89,171$130.2K0.00%+89,171New
SEI Investments Co86,725$126.6K0.00%+55,438+177.2%Added
HBK Sorce Advisory LLC70,000$65.0K0.00%+35,000+100.0%Added
Kapitalo Investimentos Ltda36,400$53.1K0.04%+36,400New
Arrowstreet Capital, Limited Partnership32,586$48.0K0.00%+32,586New
Stifel Financial Corp30,683$44.8K0.00%+1,150+3.9%Added
Prosperity Wealth Management, Inc.30,620$44.7K0.04%+30,620New
Two Sigma Advisers, LP30,300$44.2K0.00%−800−2.6%Reduced
Virtu Financial LLC30,103$44.0K0.01%−10,400−25.7%Reduced
Janney Montgomery Scott LLC30,000$44.0K0.00%00.0%Unchanged
Vigilare Wealth Management28,800$42.0K0.02%−8,000−21.7%Reduced
Susquehanna International Group, LLP28,126$41.1K0.00%+28,126New
Qube Research & Technologies Ltd27,001$39.4K0.00%+27,001New
Hunter Associates Investment Management LLC27,000$38.0K0.01%−1,500−5.3%Reduced
Caxton Associates LP25,713$37.5K0.00%+25,713New
UBS Group AG23,625$34.5K0.00%+21,641+1,090.8%Added
Cubist Systematic Strategies, LLC22,628$33.0K0.00%+22,628New
Two Sigma Investments, LP22,600$33.0K0.00%+22,600New
Personal Cfo Solutions, LLC19,388$28.3K0.01%00.0%Unchanged
Group One Trading, L.P.19,032$27.8K0.00%−2,000−9.5%Reduced
State of Tennessee, Treasury Department13,100$19.0K0.00%+13,100New
Douglas Lane & Associates, LLC13,000$19.0K0.00%+13,000New
ProShare Advisors LLC11,961$17.5K0.00%−124−1.0%Reduced
StoneX Group Inc.11,431$16.7K0.00%+11,431New
Narwhal Capital Management10,344$15.1K0.00%00.0%Unchanged
Raymond James & Associates10,048$14.7K0.00%−525−5.0%Reduced
Tower Research Capital LLC (TRC)7,988$12.0K0.00%−21,882−73.3%Reduced
Wells Fargo & Company6,200$9.05K0.00%00.0%Unchanged
Simplex Trading, LLC5,104$7.00K0.00%+3,777+284.6%Added
Citigroup Inc1,962$2.87K0.00%−4,687−70.5%Reduced
China Universal Asset Management Co., Ltd.1,469$2.15K0.00%+124+9.2%Added
Rockefeller Capital Management L.P.2,000$2.00K0.00%00.0%Unchanged
Advisor Group Holdings, Inc.1,200$2.00K0.00%−50−4.0%Reduced
BNP Paribas Arbitrage, SA937$1.37K0.00%+515+122.0%Added
Daiwa Securities Group Inc.469$1.00K0.00%00.0%Unchanged
Worth Asset Management, LLC600$8760.00%00.0%Unchanged
Carmichael Hill & Associates, Inc.525$7660.00%00.0%Unchanged
Clearstead Advisors, LLC500$7300.00%00.0%Unchanged
Signaturefd, LLC373$5450.00%−2,812−88.3%Reduced
Advisory Services Network, LLC325$4750.00%+325New
GWM Advisors LLC900$10.00%+900New
Royal Bank of Canada29$00.00%−58−66.7%Reduced
ExodusPoint Capital Management, LP0$00.00%−370,288−100.0%Sold out
Barclays PLC0$00.00%−340,068−100.0%Sold out
WS Management LLLP0$00.00%−115,602−100.0%Sold out
Alps Advisors Inc0$00.00%−88,339−100.0%Sold out
Captrust Financial Advisors0$00.00%−19,622−100.0%Sold out
RFG Advisory, LLC0$00.00%−10,000−100.0%Sold out
US Bancorp0$00.00%−16,049−100.0%Sold out
Creative Planning0$00.00%−12,878−100.0%Sold out
Running Point Capital Advisors, LLC0$00.00%−10,000−100.0%Sold out
Lindbrook Capital, LLC0$00.00%−3,084−100.0%Sold out
Quadrant Capital Group LLC0$00.00%−1,046−100.0%Sold out
Aquatic Capital Management LLC0$00.00%−1,100−100.0%Sold out
Harbour Investments, Inc.0$00.00%−200−100.0%Sold out
ACT Capital Management, LLC––––Not filed